Professional Documents
Culture Documents
3
3
and Subsidiaries
Comparative Statement of Financial Position
As of the years 2020 & 2019
2020 2019
ASSETS
Current Assets
Cash an Cash Equivalents 34,996,008,637 19,698,072,507
Receivables - Current 18,162,895,487 16,320,725,310
Inventories 24,538,009,593 23,010,504,841
Biological Assets 1,081,035,283 1,057,007,658
Financial Assets at Fair Value through profit or
15,468,905,018 15,230,438,363
loss
Derivative Assets 166,456,897 302,748,695
Available-for-sale Investments - Current 10,641,373,483 12,604,430,408
Other Current Assets 7,327,973,560 5,875,282,425
Total Current Assets 112,382,657,958 94,099,210,207
Current Liabilities
Accounts Payable and Accrued Expenses 88,549,091,936 37,619,383,555
Income Tax Payable 1,379,293,705 630,203,421
Current portion of Long Term Debts 22,674,078,899 19,553,919,868
Short Term Debts 33,097,645,087 19,397,079,998
Derivative Liabilities - 41,178,211
Other Current Liabilities 7,738,769,835 8,489,075,643
Total Current Liabilites 153,438,879,462 85,730,840,696
Shareholder's Equity
Paid - up Capital 22,015,337,650 14,085,731,314
Equity Reserve 27,306,459,166 17,619,600,043
Retained Earning 131,246,026,508 122,379,208,072
Other Comprehensive Income 3,408,824,213 1,613,242,324
Treasury Shares - - 721,848,289
Non Controlling Interest 47,827,100,701 43,499,639,414